-
Mashup Score: 0A Sampling of Studies from the 2022 ARVO Meeting - 2 year(s) ago
In what felt like an almost complete return to normalcy, in the first week of May, the Association for Research in Vision and Ophthalmology held its first live meeting in three years. Though virtual meetings were serviceable, there’s nothing like being present in the poster hall and circulating amid the presenters, or catching a podium presentation live and in-person. If you weren’t able to make…
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0
Daniel Choi, MD, and colleagues from the University of Pennsylvania, Philadelphia, investigated the effect of anti-vascular endothelial growth factor (VEGF) therapies in patients.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Effects of intravitreal anti-VEGF injections on #renal function over the long term. More: https://t.co/iEk1dwJvDf #Ophthalmology #ARVO2022 #Clinical https://t.co/0htffTRnNS
-
-
Mashup Score: 0Short period of intensive outdoor activity results in increased choroidal/central corneal thickness - 2 year(s) ago
In a poster presented at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver, Mamoru Ogawa, MD, noted that investigators have found that the choroidal and central corneal thicknesses increased over a very short period of time following intensive outdoor activity.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Short period of intensive outdoor activity results in increased choroidal/central corneal thickness. More: https://t.co/XuiVvzdYif #Ophthalmology #ARVO2022 #Cornea #Clinical #Retina #Pediatrics https://t.co/rS8AA2V1Z0
-
-
Mashup Score: 3OPT-302 combination therapy with ranibizumab shows BCVA, anatomic improvements in patients with PCV - 2 year(s) ago
At ARVO 2022, Jason S. Slakter, MD, presents data on the efficacy and safety of OPT-302 when combined with ranibizumab for polypoidal choroidal vasculopathy.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
OPT-302 combination therapy with ranibizumab shows BCVA, anatomic improvements in patients with #PCV WATCH here: https://t.co/ruFOatPLHh #Ophthalmology #ARVO2022 #Clinical https://t.co/wAqkmm3w8b
-
-
Mashup Score: 3Study evaluates OC-01 (varenicline solution) as a treatment for symptoms and signs of dry eye - 2 year(s) ago
Takeaway: there doesn’t seem to be a specific dry eye phenotype that does better or worse.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Study evaluates OC-01 (varenicline solution) as a treatment for symptoms and signs of #dry #eye More: https://t.co/PMql5tD0K7 #Ophthalmology #ARVO2022 #DryEye #DED #Corna #Clinical https://t.co/M5vPrpq9ja
-
-
Mashup Score: 0
Penny Asbell, MD, FACS, MBA, discusses “Antibiotic Resistance among Ocular Staphylococcal Pathogens: Longitudinal Trends in the ARMOR Study.”
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
ARMOR study evaluates antibiotic resistance in the treatment of #staph infections Watch: https://t.co/8hXUkQcgYs #Ophthalmology #Clinical #ARVO2022 https://t.co/XSHAdvpPTx
-
-
Mashup Score: 0
Catching up after ASCRS 2022, Ora’s Caitlin Black, senior director and therapeutic area head of medical devices, talks about the next generation of ophthalmic device therapies and diagnostics, clinical trial updates and new innovations that are most exciting for presbyopia treatment.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
VIDEO: New advancements in #IOL #technology is exciting for #presbyopia treatment Watch: https://t.co/8vIQ0JcwFE #Ophthalmology #ARVO2022 #Therapeutics #Clinical #Surgery #Refractive @oraclinical https://t.co/eSVmrJWFdF
-
-
Mashup Score: 0Phase 3 PEACHTREE, AZALEA integrated study results presented at ARVO 2022: BCVA gains, CST reduction with Xipere - 2 year(s) ago
The Phase 3 integrated PEACHTREE and AZALEA study data revealed strong safety and efficacy for triamcinolone acetonide via suprachoirodal injection.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
VIDEO: Phase 3 PEACHTREE, AZALEA integrated study results presented at #ARVO2022: BCVA gains, CST reduction with #Xipere Watch: https://t.co/ReLxH3vRf0 #Ophthalmology #ARVO22 #Clinical #Retina #Surgery https://t.co/QP2DVwlpXv
-
-
Mashup Score: 0RNA-Seq analysis identifies cell subtypes to use as models for corneal wound healing - 2 year(s) ago
At ARVO 2022 in Denver, Colorado, Timothy Blenkinsop, MD, presented “3D Eye Organoids with Distinct Cornea.” His presentation outlined how these organoids have developed sophisticated cornea structures.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
VIDEO: RNA-Seq analysis identifies cell subtypes to use as models for corneal wound healing Watch: https://t.co/zII8hNjKKv #Ophthalmology #ARVO2022 #ARVO22 #Cornea #Clinical #GeneTherapy #Therapeutics @MountSinaiNYC https://t.co/xaoDcMl7Ws
-
-
Mashup Score: 1Hot Topic: A Prognostic Liquid Biopsy for Use with Uveal Melanoma Is Predictive of Metastasis - 2 year(s) ago
Christina Herrspiegel, MD, and colleagues from the Karolinska Institute and St. Erik Eye Hospital, Stockholm, Sweden, reported that they have developed a prognostic test, referred to as serUM, that they believe is a strong predictor of metastasis of uveal melanoma.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Hot Topic: A prognostic liquid biopsy for use with #uveal #melanoma is predictive of #metastasis Read here: https://t.co/orfnxqCAOC #Ophthalmology #ARVO2022 #Clinical https://t.co/UOFPPJdWvD
-
A Sampling of Studies from the 2022 ARVO Meeting If you weren’t able to make it to this year’s meeting in Denver, here’s a look at some interesting presentations from the gathering. https://t.co/BajJmiWm8Y #retina #ophthalmology #eyecare #glaucoma #ARVO #ARVO2022 https://t.co/gv3qasN8dq